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Background: Rabies imposes a substantial burden to about half of the world popula-
tion. The World Health Organization (WHO), World Organization for Animal Health, and 
the Food and Agriculture Organization have set the goal of eliminating dog-mediated 
human rabies deaths by 2030. This could be achieved largely by massive administration 
of post-exposure prophylaxis—in perpetuity—, through elimination of dog rabies, or 
combining both. Here, we focused on the resources needed for the elimination of dog 
rabies virus by 2030.
Materials and methods: Drawing from multiple datasets, including national dog 
vaccination campaigns, rabies literature, and expert opinion, we developed a model 
considering country-specific current dog vaccination capacity to estimate the years and 
resources required to achieve dog rabies elimination by 2030. Resources were deter-
mined based on four factors: (a) country development status, (b) dog vaccination costs, 
(c) dog rabies vaccine availability, and (d) existing animal health workers. Our calculations 
were based on the WHO’s estimate that vaccinating 70% of the dog population for 
seven consecutive years would eliminate rabies.
Findings: If dog rabies vaccine production remains at 2015 levels, we estimate that 
there will be a cumulative shortage of about 7.5 billion doses to meet expected demand 
to achieve dog rabies elimination. We estimated a present cost of $6,300 million to elim-
inate dog rabies in all endemic countries, equivalent to a $3,900 million gap compared 
to current spending. To eliminate dog rabies, the vaccination workforce may suffice if all 
public health veterinarians in endemic countries were to dedicate 3 months each year to 
dog rabies vaccination. We discuss implications of potential technology improvements, 
including population management, vaccine price reduction, and increases in dog- 
vaccinating capacities.
conclusion: Our results highlight the resources needed to achieve elimination of 
Abbreviations: DEC, dog rabies endemic country; FAO, Food and Agriculture Organization; HDI, human development index; 
GDREP, global dog rabies elimination pathway; NGO, non-governmental organization; OIE, World Organization for Animal 
Health; PEP, post-exposure prophylaxis; RIG, rabies immunoglobulin; WHO, World Health Organization.
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…it is villainous that our pounds should be so little 
patronized and such swarms of dogs allowed to run 
unmuzzled….[Dogs] swarm in all the streets, obstruct 
the pavements, make night hideous with their howls… 
New York Daily Times (1)
inTrODUcTiOn
The control of dog rabies presents a unique and challenging 
undertaking. The One-Health nature of rabies—requiring the 
integration of medical and veterinary sectors—has challenged 
how animal control and rabies prevention efforts are designed 
and implemented. Animal control has posed a challenge for 
centuries (1, 2), as suggested by the epigraph, which continues 
to resemble many urban and peri-urban settings today. Rabies 
is a zoonotic disease that kills an estimated 59,000 people and 
hundreds of thousands of animals annually, with most of the 
burden falling in low- and middle-income countries, particularly 
among children and poor urban and rural communities (3, 4). 
About 99% of rabies human cases originate by rabid domestic 
dogs (4–7). Few other zoonotic diseases have provoked the same 
sense of terror in humans as rabies, and dog bites in general 
have been a focal issue in the control of dog populations (1, 8). 
Controlling dog rabies substantially reduces human exposures 
(9, 10) and can be accomplished through periodic campaigns of 
dog vaccination (9, 11, 12). World Health Organization (WHO) 
recommends recurrent vaccination campaigns covering at least 
70% of the dog population to control and potentially eliminate 
dog rabies (7, 13, 14).
The One-Health character of rabies has for centuries 
illuminated inherent divisions of responsibilities between 
institutions focused on animal health and human health. This 
has often complicated and delayed the development of mod-
ern rabies control programs, as most early efforts to control 
rabies were relinquished to non-public health agencies (1). As 
public health agencies became more involved in rabies pre-
vention, particularly after the introduction of post-exposure 
prophylaxis, they remained primarily reactive, providing care 
to humans after a potential rabies exposure (2). Even today, 
determining whether health or agriculture has responsibility 
for leading control efforts often impedes initiation of rabies 
control plans (7).
Despite these challenges, dog rabies has been successfully 
eliminated in most of the Western Hemisphere, western Europe, 
and some Asian countries. Effective control of dog rabies at the 
community level through dog control programs (e.g., confine-
ment, stringent leash-law legislation, and destruction of stray ani-
mals) began in parts of Europe as early as the nineteenth century 
(2). However, mass vaccination programs starting in the 1920s 
and 1930s were largely responsible for the elimination of dog 
rabies in Canada, Europe, Japan, and the United States (2, 15–18). 
Similarly, regional rabies control efforts in Latin America, with 
support from the Pan American Health Organization, were initi-
ated in the early 1980s and have been successful in reducing the 
number of reported cases of rabies in dogs by 98% (19–21). These 
success stories have resulted from a combined effort involving 
mass dog vaccination, dog population control, and coordination 
at national and community levels, all supported and promoted by 
national governments (2, 22, 23).
In 2016, the WHO, the World Organization for Animal Health 
(OIE), the Food and Agriculture Organization (FAO), and many 
non-governmental organizations agreed to mobilize their mem-
ber states, portfolios, and resources to eliminate dog-mediated 
human rabies by 2030 (24, 25). Many dog-rabies endemic coun-
tries (DECs) are at the early stages of their control efforts and 
are still overcoming barriers related to limited understanding of 
the local epidemiology, logistic and operational challenges, lack 
of resources, and competing priorities of other diseases (3, 26, 
27). Many of these barriers have been addressed and overcome 
by other nations, affording the opportunity for those countries 
still at early stages to benefit from prior experiences (4, 6, 26, 28).
This analysis intends to provide both a realistic assessment and 
feasible projections for a path toward global dog rabies elimina-
tion by 2030 through dog vaccination. Building on previous expe-
rience of dog vaccination programs (7, 19, 21, 29), we focused on 
four factors that are likely to affect a country’s ability to eliminate 
dog rabies: country development, cost of vaccinating 70% of the 
dog population, dog rabies vaccine production, and availability 
of trained personnel for vaccine administration. We considered 
and evaluated several categories of plausible technological 
improvements and innovations as a sensitivity analysis, includ-
ing increasing vaccination capacity, decreasing vaccine costs, 
and massive dog population management efforts. Our results 
quantitatively highlight some of the main challenges and provide 
overview of possible modifications, directions, and pathways to 
be considered. Our goal is to provide a realistic description of the 
dog-mediated human rabies deaths by 2030. As exemplified by multiple successful 
disease elimination efforts, one size does not fit all. We suggest pragmatic and feasible 
options toward global dog rabies elimination by 2030, while identifying several benefits 
and drawbacks of specific approaches. We hope that these results help stimulate and 
inform a necessary discussion on global and regional strategic planning, resource mobi-
lization, and continuous execution of rabies virus elimination.
Keywords: infectious disease, rabies control and prevention, dog vaccination, population management, zoonotic 
diseases, one health, global health, rabies elimination
FigUre 1 | global Dog rabies elimination Pathway (gDreP): phases for a dog rabies elimination program based on 70% dog population vaccination 
coverage. Notes: there is variation between and within countries for the implementation and scaling-up of national dog vaccination campaigns. Based on expert 
opinion from dog vaccine implementation strategies in Haiti, Ethiopia, United States, Vietnam, and Latin America, we assumed that the current dog rabies 
vaccination coverage was directly correlated to the number of years it will take to achieve elimination, as illustrated by the three distinct phases shown in the figure. 
For countries in Phase II, we estimated dog vaccination as the median value in the corresponding year range (e.g., we used 26% vaccination coverage in the rage 
18–35%), or the current country vaccination rate for those countries that were already vaccinating dogs at a rate equivalent to Phase II. *Infrastructural improvement 
costs were estimated to be equivalent to the cost of vaccination for 10% of the country’s unvaccinated dog population.
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status quo and present gaps hampering possible elimination. In 
particular, this manuscript highlights the urgent need to initiate 
action among public health officers, donors, academics, and the 




We combined multiple data sources to derive quantitative estimates 
of the four factors that are likely to influence the feasibility of dog 
rabies elimination by means of dog vaccination: country develop-
ment, cost of dog vaccination programs, potential demand for dog 
vaccine, and the current number of trained dog vaccination person-
nel (e.g., para-veterinarians). We included a total of 192 countries in 
our analysis. We classified countries as either DECs or dog rabies-
free countries and used United Nations (UN) geographic regions to 
group them to summarize our main results (30). For the purposes 
of this study, we assumed constant human, dog, and health-care 
worker populations for the time period 2017–2030.
Framework for eliminating Dog rabies
We developed a theoretical global dog rabies elimination pathway 
(GDREP) consisting of a 13-year time frame; with the assumption 
that this would be enough time for even the least-developed rabies 
control programs to achieve elimination by 2030 if they fully 
committed to this achievement. A country’s starting point within 
the GDREP timeframe was dependent upon their current (2015) 
estimated dog vaccination rate, and each country was assumed to 
progress through the program in annual increments. We assumed 
that all DECs would start the program at the same time (January 
1, 2017), and that countries would progress through each annual 
stage of the program without regress.
Dog vaccination programs typically rely on robust logistical 
support, including infrastructure and human capital (31–34). 
Based on expert opinion from dog vaccine implementation 
strategies in Haiti, Ethiopia, United States, Vietnam, and Latin 
America, we assumed that the current dog rabies vaccination 
coverage was an indicator of a country’s capabilities to conduct 
mass dog vaccination campaigns. We divided the GDREP into 
three phases (Figure 1), as a function of their current dog vac-
cination rates. In this framework, a countries would progressively 
move toward phase III, a threshold at which they would conduct 
a full-scale dog vaccination campaign.
Countries with current dog vaccination coverage below 18% 
(i.e., 25% of WHO’s goal of 70% of the dog population vaccinated) 
were classified as Phase I. These countries entered the program at 
year 1, and we estimated that they would need the full 13 years 
to achieve elimination. Phase I countries were given 3  years to 
develop field studies, workforce training, adequate legislation, and 
other infrastructural improvements. We estimated the annual cost 
for each of the 3 years that these countries remained in Phase I as 
the country-specific cost of the 2015 dog vaccination efforts plus 
the cost for these infrastructural developments. Because we found 
no available evidence of the costs to scale-up a fledgling rabies 
vaccination program, and the exact amount is likely to vary from 
country to country based on available capabilities and dog popu-
lation size, we defined the costs of infrastructural developments 
as approximately the cost to vaccinate 10% of the dog population 
that remained to be vaccinated. The 10% was estimated based on 
CDC’s dog vaccination support activities in Haiti (27, 35, 36).
Countries with vaccination coverage above 18% and below 
70% were classified as Phase II. Phase II was equally divided into 
three 1-year periods based on current dog vaccination: 18–35% 
coverage countries entered the program at year 4, 36–53% cover-
age countries entered at year 5, and 53–69% coverage countries 
entered the program at year 6. Phase II countries were charged an 
annual rabies elimination cost equal to their current dog vaccina-
tion efforts plus the cost to vaccinate an additional 10% of their 
dog population. These additional costs were estimated to be nec-
essary to further develop their mass dog vaccination programs, 
focused on scale-up of services, logistical improvements, and 
pilot implementation of elimination programs. Depending on 
the estimated 2015 dog vaccination rates, countries entering the 
program in Phase II could take 8–10 years to achieve elimination.
TaBle 1 | Main parameters and data sources to inform the estimates for 
global Dog rabies elimination Pathway (gDreP), 2017–2030.
Parameter Value source
Demographic and epidemiological data
Human population Country specific (37)
Urban population (%) Country specific (37)
Human-to-dog ratios (humans per dog) Mean: 10.8 Estimated
Asia and Oceania Urban: 7.5; rural: 14.3 (6)
China Urban: 48.3; rural: 48.3 (6)
Africa Urban: 21.2; rural: 7.4 (6)
The Americas Urban: 7.5; rural: 7.5 (19)
Europe Urban: 6.5; rural: 6.5 Estimate
HDI Country-specific (38)
Dog vaccine administration
Vaccination coverage needed 70% (7, 13, 14)
Vaccinated dogs by country Country specific (4)
Daily vaccination capacitya 100 dogs/day/person (39)
Animal health workers
Public health veterinarians Country specific (40)
Public health para-veterinarians Country specific (40)
cost to vaccinateb
Cost per dog vaccinated (point estimate) $2.18 (41–43)
Vaccine, syringes, and needles (%) 26.8 (41, 42, 44)
Personnel (%) 28.5 (41, 42, 44)
Overhead and other costs (%) 44.7 (41, 42, 44)
Discounting rate (%) 3 (45)
Dog population managementc
Share of female dogs sterilized in first 
round (%)
70 (46)
Maintenance sterilization (%) 30 (46, 47)
Reduction in dog population over  
5 years (%)
40 (47, 49)
Cost per female dog sterilized $8.00 (47, 49)
HDI, human development index; it is a composite measure of health, education, and 
income used by the United Nations Development Program (38).
aDog vaccination capacity is consistent with unpublished data collected by the authors 
of this analysis in urban, semi-urban, and rural areas of Haiti.
bAll costs were adjusted to 2015 US dollars using gross domestic product implicit price 
deflators (48).
cThe dog population management scenario is based on the expected/plausible 
technological developments in coming years.
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Countries with vaccination coverage currently at or above 70% 
were classified as Phase III. Based on WHO recommendations, 
we estimated that countries would have to vaccinate 70% of the 
dog population for 7  years to eliminate dog rabies (7, 13, 14). 
All DECs currently vaccinating at 70% entered the program at 
year 7, and required 7  years to achieve elimination. Therefore, 
if all DECs committed to dog rabies elimination in 2017 and 
progressed through this program, the earliest a country could 
achieve elimination is 7  years and the longest it would take is 
13 years.
analysis and input Data
Country-specific estimates for each of the four factors evaluated 
in this study (i.e., country development, cost of dog vaccination 
to achieve goal, expected number of dog vaccines required, and 
currently trained personnel) were derived and then aggregated 
by UN Regions and at the global level. Table 1 shows the main 
parameters and sources of data used to obtain the estimates in this 
study. We obtained country populations and proportion residing 
in urban areas for the year 2015 from the World Bank (37).
We estimated country-specific dog populations by applying 
regional human-to-dog ratios to each country’s human popula-
tion based on previous literature (6, 19) (Table 1). We calculated 
dog populations for both urban and rural areas, and the total was 
represented as the summation of these two values. We obtained 
estimates of dog rabies vaccination coverage from Hampson 
et al. (4).
We estimated country-specific veterinary workforce using data 
from OIE (40), based on two optimistic scenarios: (A) all public 
health veterinary workforce is available to provide dog rabies vac-
cinations (including private and public practice) and (B) that all 
public health para-veterinarian workforce is available to provide 
dog rabies vaccinations. For each scenario, we calculated the 
potential gap or surplus in vaccinator capacity for programs that 
operate both 1- and 3-month vaccination campaign duration. We 
calculated the capacity by country and then aggregated it globally. 
Information on veterinary workforce is voluntarily provided by 
countries. We imputed the size of the animal health workforce, 
weighted by country cluster, for countries for which data were 
not available.
The cost to vaccinate a dog is variable and may differ from 
country to country. We estimated the cost to vaccinate a dog 
based on the average inflation-adjusted estimate from articles 
of dog vaccination costs to prevent rabies in three developing 
countries: Chad (41), Tanzania (42), and the Philippines (43). 
These costs included vaccine costs (e.g., syringes, certificates, 
vaccine), equipment, cold chain, dog vaccinators’ salaries, 
transportation, awareness, and information, among others, 
but the specific items included varied by study. We used other 
published estimates to inform our sensitivity analysis on costs 
per vaccine (6, 44, 49). We focused solely on dog vaccination; we 
did not include other costs associated with rabies control, such 
as rabies surveillance, laboratory diagnostics, or training dog 
vaccination personnel, which despite being integral to an effec-
tive rabies control program cannot be readily quantified and are 
unlikely to change the overall conclusions of our analysis. We 
used a 3% discount rate in all our estimates (45), and adjusted 
all cost to 2015 US dollars using US gross domestic product 
implicit price deflators (48).
Dog rabies vaccine production is a potentially limiting factor 
in the effort to eliminate dog rabies globally. The 2015 estimated 
number of dog rabies vaccines used in 2015 was obtained from 
Hampson et al. (4). This current DEC dog rabies vaccine demand 
was assumed to approximate the supply, as there have been no 
reports of large-scale expiration of animal rabies vaccines. We 
compared the current supply of vaccine to DECs to the antici-
pated annual demand from 2017 to 2030 and calculated the gap 
in current supply to anticipated demand.
Last, we ranked the UN Regions in terms of likelihood of 
achieving dog rabies elimination based on aggregate indicators 
of the four factors used in our country-level analysis, plus two 
regional indicators. Criteria included: country development 
index, estimated funding gap for elimination, current dog vac-
cination coverage, gap in vaccinator capacity, proportion of the 
cluster that was considered rabies free, and expected years to 
TaBle 2 | Main assumptions that inform our estimates.
assumption rationale
70% of the dog population has 
to be vaccinated annually for 
5–7 years to eliminate dog rabies
WHO recommendation; research suggests 
70% threshold (7, 13, 14). Caveat: possibly 
varies by setting (55)
Dog vaccination coverage 
estimated by Hampson et al. (4) is 
reasonably accurate
Refereed review; provides country-specific 
estimates
Regional human-to-dog ratios 
estimated by Knobel et al. (6) are 
representative of countries in each 
region
We crossed-checked using human-to-dog 
ratio estimated from Davlin and VonVille 
(29) and found a ~3% aggregate difference
Countries where rabies has been 
eliminated from specific regions 
within the country (e.g., Brazil) 
still require national vaccination 
coverage
Our aim is not to explore detailed trends at 
the subnational level but to illustrate global 
trends
The time frames presented in 
the GDREP accurately reflect 
a country’s progression toward 
elimination
However, we recognize that between and 
within country capabilities and willingness 
to conduct dog rabies elimination 
campaigns using vaccines will, in reality, 
vary
All countries commit to dog rabies 
elimination at year 1 of GDREP 
and move through the phases as 
predicted
While this assumption is unlikely to reflect 
reality, this analysis and supplementary 
table can be used to forecast needs on a 
country-specific level
After 7 years of vaccination of 70% 
of dog population, we consider 
the country rabies free and do not 
longer estimate dog vaccination 
maintenance costs
Countries completing the GDREP will 
likely continue to fund rabies prevention 
programs and maintain some level of 
dog rabies vaccination. However, these 
activities are no longer for the purpose of 
elimination, rather they are for the purpose 
of preventing re-incursion of the virus. 
Therefore, these costs are not considered
Vaccination capacity: all public 
health veterinary work force 
would be willing/able to do dog 
vaccinations, and veterinary 
workers can move within countries 
at ease. We assume the workforce 
reported by OIE (40) is reasonably 
accurate
Larger cities may have an unequal 
distribution of vaccination capacity. This 
is not accounted for under the vaccinator 
capacity assessment
WHO, World Health Organization; OIE, World Organization for Animal Health; GDREP, 
Global Dog Rabies Elimination Pathway.
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achieve elimination. Each of the six criteria was ordered from 
most optimal to least optimal value and received the correspond-
ing numerical score. We summed the country cluster rank scores 
to obtain a cumulative rabies elimination rank score. Lower 
scores represent UN Regions that appear to be more favorably 
situated to achieve the rabies elimination goal.
sensitivity analysis, Main assumptions, 
and robustness checks
To assess what future efforts might have the greatest impact on 
global dog rabies elimination, we developed four hypothetical 
scenarios assuming that a new technology would be developed 
which would impact the feasibility of dog vaccination. These 
illustrative scenarios included a 50% decrease in the price of dog 
rabies vaccine (including syringe and needle), 50% and 100% 
increases in the daily vaccination capacity of a vaccinator, and a 
global reduction in the dog population to a level that is presumed 
to be sustainable under currently available resources (a 40% 
reduction in population) (46, 47). We estimated the distribution 
of the aggregate costs of dog vaccination campaigns by compo-
nent (vaccines, syringe and needles, personnel, and overhead and 
other costs) based on the average cost distribution accrued during 
dog vaccination campaigns in Chad and Tanzania (41, 42, 44).
Daily vaccination capacity is likely to vary depending, among 
other factors, on vaccinator experience, dog density, and dog 
owner reception to vaccination (39, 50–53). A large-scale cam-
paign in an African city was able to vaccinate approximately 
100 dogs per person, per day (39). This figure is consistent with 
unpublished data collected by the authors of this analysis in urban, 
semi-urban, and rural areas of Haiti and was used for vaccinator 
capacity calculations. Other estimates for daily dog vaccination 
capacity (median number of dogs vaccinated per person per day) 
include ~9 in Mali (54), ~21 in Chad (51), ~50 in a different area 
of Chad (53), ~25 in Guatemala, and ~100 in Haiti (unpublished 
data collected by CDC). A much higher estimate was obtained in 
Malawi (39) where ~200 dogs were vaccinated per person per day 
in each static point station. We used a 50% increase to 150 dogs 
per day and a 100% increase to 200 dogs per person per day for 
our sensitivity analysis, because we were interested in showing 
the results from the best plausible scenarios of dog vaccination.
Last, we assumed a new technology for relatively inexpensive, 
effective management of dog populations would be developed; 
it would be capable of effecting a 40% decrease in the total dog 
population over a 5-year period and would cost US$8, similar 
to the current cost of sterilizing a female dog (46, 47, 49). We 
assumed that dog population management activities would 
require reasonable country infrastructure and would therefore 
begin during Phase II of the GDREP. The scenario required a one-
time 70% sterilization of the female dog population to achieve a 
40% population reduction and maintenance of this population 
through continued sterilization of 30% of female dogs (45, 46).
The results from our model are based on several critical 
assumptions, informed by previous literature, dog vaccination 
campaigns, and expert opinion. For transparency and ease of 
understanding, we provide a list of the main assumptions of our 
model and their rationale in Table 2.
We conducted a robustness check on two key parameters. 
First, we assessed whether our estimate of dog population was 
reasonable, by calculating the global dog population based on 
human-to-dog ratios obtained from Davlin and VonVille (29). 
Second, we checked the robustness of the assumption that 
the current dog rabies vaccination coverage was an indicator 
of a country’s capability to conduct mass dog vaccination 
campaigns by comparing current dog vaccination rates to their 
UN-defined human development index (HDI). The HDI is an 
aggregate composite index of life expectancy at birth, mean of 
years of schooling, and gross national income per capita (38). 
The UN’s HDI is a method of quantifying the development of a 
country in a more robust manner than economic growth alone. 
TaBle 3 | association between human Development index (hDi) and dog rabies vaccine coverage and elimination.
Dog rabies free Dog rabies endemic current dog vaccination coverage, endemic countries
>70% 53–69% 35–53% 18–35% <18%
Countries 70 122 5 9 24 28 56
Total HDI scorea 54.30 73.04 3.49 6.38 18.18 18.91 26.09
HDI range 0.43–0.95 0.28–0.89 0.63–0.77 0.57–0.89 0.45–0.88 0.43–0.85 0.28–0.77
Mean HDI score 0.78 0.60 0.70 0.71 0.76 0.68 0.47
95% CI 0.76–0.80 0.58–0.62 0.57–0.83 0.63–0.79 0.71–0.81 0.64–0.72 0.44–0.50
SD 0.13 0.16 0.05 0.10 0.06 0.12 0.12
Test of significance; two-tailed t-test: p < 0.05; ANOVA: p = < 0.05.
CI, confidence interval.
aHDI is a composite measure of health, education, and income used by the United Nations Development Program to rank countries based on their human development (38).
6
Wallace et al. Global Dog Rabies Elimination Pathway
Frontiers in Veterinary Science | www.frontiersin.org February 2017 | Volume 4 | Article 9
We compared HDI to dog vaccination coverage among DECs, 
with mean, SD, and analysis of variance calculated to determine 
if significant differences were present. Development measures, 
such as HDI, have been used as benchmark for health system 
capabilities in other studies of disease burden (4, 56–59).
resUlTs
Dog Populations
Our estimates show that there are approximately 687 million dogs 
globally (an average global human-to-dog ratio of 11:1), of which 
536 million resided in the 122 DECs (78.1%) in 2015. Based on 
the WHO’s recommendation of 70% vaccination coverage during 
7  years for elimination (7, 13, 14), a total of 375 million dogs 
would need to be immunized in DECs. An estimated ~130 mil-
lion dog rabies vaccines were utilized in 2015, representing a gap 
of 246 million annual dog vaccinations to achieve the desired 
vaccination goal of 70% (country-specific estimates are shown 
in the Supplementary Material) (4). We compared these global 
estimates of dog population with estimates based on Davlin and 
VonVille’s (29) human-to-dog ratios. While differences were 
noted between individual country estimates, estimates of the 
global mean were within 2.5% difference, not statistically differ-
ent (paired t-test, p-value = 0.96).
human Development index
Seventy countries were determined to be dog rabies virus free; 
122 were categorized as DECs. Countries free of dog rabies 
(n  =  70) had a significantly higher mean HDI score of 0.78 
compared to 0.60 for DECs (p < 0.05). Five mean HDI scores 
were calculated in accordance with the 13-year vaccination 
program phases and are displayed in Table 3. Only 5 DECs were 
estimated to be vaccinating more than 70% of dogs as of 2015 
(Phase III); 56 (46%) were vaccinating less than 18% (Phase I). 
The remaining 61 DECs were defined as Phase II. The mean 
HDI score for DECs in Phase I was significantly lower than 
DECs in Phases II and III (mean 0.46 vs 0.71, p = 0.004). We 
interpreted this to suggest that significant structural improve-
ments would be needed in these countries before sustained 
higher dog vaccination levels could be achieved, which vali-
dated our assumption that current dog vaccination coverage is a 
reasonable indicator of a country’s capabilities to conduct mass 
dog vaccination campaigns (specific details are shown in the 
Supplementary Material).
Dog Vaccines required
Figure 2 shows the number of dog vaccinations required annually 
for the 13-year dog rabies elimination program. The line shows 
the number of dog vaccinations estimated to have occurred in 
2015 as a reference (n ≈ 130 million). The results suggest that, if 
the current scenario does not change, by the second year of the 
GDREP, we would require additional production of at least 30 
million doses. The largest gap in dog rabies vaccines is predicted 
to occur in year 7 of the program, with a potential gap of 245 
million doses. However, this spike in dog vaccine needs is model 
dependent, as it corresponds to the point where we would expect 
the largest number of countries vaccinating at 70%, if all countries 
begin in year 1 and progress as expected. The cumulative dog 
rabies vaccine gap for the duration of the 13-year program is 
7.5 billion doses, assuming vaccine production remains at the 
estimated 2015 level.
Vaccination costs
Using an average cost per dog vaccinated of $2.18, based on 
estimates from vaccination campaigns in three developing 
countries (Table 1), we estimated a total present cost of $6,315 
million to eliminate dog rabies in all DECs. Most DECs are cur-
rently vaccinating some proportion of their dog population, at an 
estimated value of $2,457 million over the course of the 13-year 
elimination program. Therefore, the additional present cost of 
dog vaccination to achieve elimination would be $3,858 million. 
An estimated $299 million is required to move all Phase I coun-
tries into Phase II; $1,386 million to move all Phase II countries 
to Phase III, and $4,631 million to move all countries through 
Phase III, elimination. Year 1 of the global elimination program 
is anticipated to have a funding gap of $60 million (Figure 3). The 
funding gap is anticipated to reach a peak in year 7 of the global 
campaign ($448 million).
The costs of vaccinating a dog vary substantially within and 
between countries (6, 41–44). Figure 4 shows the aggregate cost 
of eliminating dog rabies for a range of estimates of unit costs 
per dog vaccinated derived from previous studies. If the mean 
cost to vaccinate a dog was as high as $8.60, then the gap for 
global elimination could be $13.5 billion. If the cost to vaccinate 
a dog could be reduced to approximately $0.30, there would be no 
FigUre 2 | annual dog vaccinations required to achieve rabies elimination goal by 2030. Notes: the estimates show aggregate values of canine vaccination 
requirements for countries, assuming that all countries begin working toward rabies elimination in the first year. The estimates are based on current human and dog 
population and vaccine availability.
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anticipated gap in funding to achieve global elimination. At $0.30 
per dog vaccinated, this value is sevenfold lower than the current 
most likely cost ($2.18).
animal health Workers’ Vaccination 
capacity
Using data for animal health work force from OIE (40), we 
estimated each country’s dog vaccination capacity. We estimated 
that each worker would be able to vaccinate 100 dogs per day 
(39), and compared animal workforce requirements for a single 
1-month vaccination campaign (25 work days) compared to a 
3-month campaign.
Figure 5 shows the aggregate results for annual dog vaccination 
capacity (total dogs potentially vaccinated by existing workforce) 
for (A) all public health veterinary workforce (n = 115,864) and 
(B) all public health para-veterinarian workforce (n =  39,635). 
Under scenario (A), our estimates show that there will be a global 
shortage of dog vaccinators in year 5 of the GDREP, assuming 
1-month vaccination programs are utilized. Dog vaccinator 
shortages would reach their peak in year 10 of GDREP, at 91 mil-
lion dogs unable to be reached for vaccination. The vaccinator 
workforce may be adequate if they were to dedicate 3-months 
each year to dog rabies vaccination.
Under scenario (B), utilizing only the para-veterinarian work-
force for dog vaccination, we would expect an immediate work-
force shortage in year 1 under GDREP when utilizing a 1-month 
vaccination program. Dog vaccinator shortages under this method 
would peak in year 7, at 276 million dogs unvaccinated. If this 
para-veterinary workforce were to dedicate 3-months toward dog 
rabies vaccination, a shortage in workforce would still be expected 
in year 5 of the GDREP and peak in year 7 (expected shortage of 
132 million dogs) (further details about country capacity by year 
are shown in the Supplementary Material).
sensitivity analysis: hypothetical 
scenarios Based on Technological 
improvements
The four scenarios based on hypothetical technological improve-
ments to reasonably improve current dog vaccination practices 
included a 50% decrease in the price of dog rabies vaccine, a 50% 
and 100% increase in the daily vaccination capacity of a vaccina-
tor and a 40% global reduction in the dog population (46, 47).
Figure 6 shows the annual costs of dog rabies elimination in 
endemic countries under each of the four hypothetical scenarios. 
The results suggest that, based on the limited existing evidence 
of dog population management, massive sterilization campaigns 
with current technology are the costliest path toward global rabies 
elimination. The spike in aggregate costs around the fourth year 
corresponds to our assumption that countries currently lagging 
in dog vaccination would be able to conduct massive sterilization 
only once they have achieved the capabilities of implementing 
massive vaccination campaigns.
Figure 7 compares the total costs of each of these hypothetical 
scenarios. Reduction of the cost of the rabies vaccine (including 
syringe and needle) by 50% would equate to an overall 13% 
reduction in the global cost to eliminate dog rabies ($5,471 mil-
lion). Increasing daily capacity to vaccinate dogs from 100 dogs 
per person to 150 dogs per person would result in an expected 
~10% reduction in total program costs, and increasing the daily 
capacity to 200 dogs per person/day would yield a net cost 
FigUre 4 | Variability of the aggregate costs of gDreP based on the costs of administering rabies vaccines to 70% of the dog population, in rabies 
endemic countries, for a range of unit costs per dog vaccinated. Notes: costs are in 2015 US dollars; we used a 3% discount rate (45). Unit costs per dog 
vaccinated were informed by previous economic studies of dog vaccination (6, 41–44, 49). GDREP denotes Global Dog Rabies Elimination Pathway.
FigUre 3 | global annual costs of dog rabies vaccine administration to achieve dog rabies elimination in endemic countries, and number of 
countries with endemic rabies. Notes: costs are in 2015 US dollars; we used a 3% discount rate (45).
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reduction of ~14%. Based on an estimated cost for spay surgery of 
$8, a 40% reduction in the global dog population would result in 
a ~29% reduction in rabies vaccination program costs. However, 
the cost necessary to achieve global dog population reduction was 
estimated at $4,331 million, and thus, the overall program cost 
was ~40% higher than the current estimate for elimination based 
solely on dog vaccination with no population management. The 
costs per female dog sterilized would need to be reduced to less 
FigUre 5 | annual surplus or deficit of global dog vaccination capacity (total dogs potentially vaccinated by existing workforce) to achieve rabies 
elimination in dog rabies endemic countries based on (a) public health veterinary workforce and (B) public health para-veterinary workforce. Notes: 
workforce data were obtained from the World Organization for Animal Health (40); the vaccination capacity was estimated for each country with dog endemic rabies 
and then aggregated at the global level. The estimates are based on a dog vaccination capacity of 100 dogs per worker per day (39).
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than half the price, about $3.50 per dog, to make the costs of dog 
population management plus dog vaccines comparable to that of 
only vaccinating dogs.
Prioritization for global Dog rabies 
elimination
The UN define 22 clusters of countries. Of these clusters, six were 
free of dog rabies. Of the remaining 16 clusters in which dog rabies 
is currently endemic, our applied elimination scores ranged from 16 
to 84 (Table 4). Clusters with the lowest elimination scores were pri-
marily located in the Western Hemisphere and Europe (Figure 8). 
Countries with the highest scores were mainly located in Africa and 
Asia. The 16 ranked clusters were stratified into three groups. Group 
1, consisting of seven countries, had a mean HDI of 0.77, compared 
to 0.65 and 0.47 for the second and third groups. Group 1, with the 
lowest elimination scores, had a mean elimination time of 5.4 years, 
compared to 10.1 and 11.7 years for Groups 1 and 2.
DiscUssiOn
The goal set forth by WHO, OIE, FAO, and global experts for the 
elimination of dog-mediated human rabies deaths will undoubt-
edly be the impetus for numerous countries to improve their 
rabies control and elimination programs. Achieving this global 
target will take international coordination from governments, 
non-government entities, private industry, educational institu-
tions, and many more partners. Establishing a framework that 
clearly describes the challenges that these partners will face is a 
critical first step in developing both regional and global strategies. 
There are several key approaches for how countries might achieve 
this goal; however, only mass vaccination of dogs has been 
effectively proven as a sustainable and cost-effective method. In 
this assessment, we have attempted to describe the scope of the 
resources that will be required to eliminate dog-mediated human 
rabies deaths through mass vaccination of dogs. In our attempt to 
conduct this global analysis, we made several critical assumptions 
to develop a model of an ideal scenario of dog rabies elimination. 
We focused on quantitative, measurable factors that affect a coun-
try’s ability to eliminate dog rabies, but there are many qualitative 
aspects of rabies control that would need careful consideration 
when assessing individual country prospects for elimination. The 
capacity to eliminate dog rabies varies by country, with unique 
challenges and opportunities that cannot be readily quantified or 
generalized. These include, but are not limited to, political sup-
port, economic support, political stability, veterinary capacity, 
dog ownership characteristics, legislation, and dog ecology. We 
acknowledge that there is variation between and within countries 
for the implementation and scaling-up of national dog vaccina-
tion campaigns. However, the purpose of this analysis was not to 
provide a detailed roadmap for countries to follow toward rabies 
FigUre 6 | annual costs of dog rabies control under four hypothetical scenarios: decrease in the price of dog rabies vaccine, (including syringe and 
needle) increases in daily vaccination capacity of health workers, and effective dog population management and control. Notes: the four hypothetical 
scenarios assuming that a new technology impacted the feasibility of dog vaccination, reasonably improving current practices. The estimates are based on current 
human and dog population and vaccine availability. The distribution of aggregate costs components was estimated based on previous literature (41, 42, 44).
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elimination, but rather to provide evidence for regional and global 
leaders to continue to advocate for resources, be they monetary, 
human, or material, to support global rabies elimination efforts.
At first glance, the feasibility of global dog-mediated human 
rabies elimination through mass dog vaccination is sobering. Of 
the four main factors assessed in this analysis, three are likely 
to represent substantial barriers to this goal: country capabilities 
(measured by HDI), vaccine demand, and funding. We have pre-
dicted gaps in the availability of dog rabies vaccines to the order 
of hundreds of millions. The cost of global elimination is likely 
to be billions of dollars. In a recent WHO expert consultation 
(7), scaling-up of animal rabies vaccines was determined to be 
possible, but the degree of expansion was not reported. However, 
with more countries developing the technology to produce local 
animal rabies vaccines (e.g., Ethiopia, India, and China), and 
growing demand for dog vaccines, the regional supply could be 
expanded. Clearly, local capacity building, regional approaches, 
and joint attempts for funding mobilization would be critical 
components of elimination efforts.
As a neglected disease, rabies control will always be susceptible 
to priority shifting based on new agendas or more urgent public 
health threats. New tools like the Stepwise Approach toward 
Rabies Elimination and the One-Health Prioritization tool may 
help nations to identify if rabies is a priority and make necessary 
steps to develop sustainable elimination plans. Development of 
regional consortiums to support national elimination planning, 
coordinate efforts between countries, share surveillance data 
and technical assistance, and leverage regional resources may 
be critical in achieving global elimination. The Rabies Program 
Directors of the Americas have followed this model and have 
been a critical component of the successful elimination efforts 
in Latin America.
To assess the importance of a country’s overall human develop-
ment and its relationship to public health programs, we adapted 
the HDI as an indicator of a country’s capabilities to conduct 
effective mass vaccination campaigns. While rabies elimination 
successes are not limited to high-income countries, dog rabies-free 
countries had a significantly higher HDI compared to countries 
that have not yet achieved elimination. This finding has two main 
implications for the interpretation of this study. First, it supports 
several assumptions used to create the GDREP, particularly the 
assumption that countries with lower vaccination coverage will 
probably require more time and monetary inputs before effective 
mass vaccination campaigns are realized. Second, this finding 
suggests that the resources available today may not be adequate 
for dog rabies elimination in the resource-poor countries that 
remain endemic. High levels of international support (ranging 
from monetary to technical assistance) have been provided in 
Tanzania, Chad, Malawi, and Haiti to achieve adequate dog vac-
cination coverage. As the global community prepares to provide 
support for dog rabies elimination, considerations for supporting 
national infrastructure should be considered.
World Organization for Animal Health vaccine bank mecha-
nisms for lower cost procurement of vaccines is one of the most 
recent developments, which may facilitate vaccine acquisition 
and distribution. However, with the likely increase in dog vaccine 
FigUre 7 | aggregate costs of dog rabies control (2017–2030) under four hypothetical scenarios: decrease in the price of dog rabies vaccine 
(including syringes and needles), increases in daily vaccination capacity of health workers, and effective dog population management and control. 
Notes: the four hypothetical scenarios assuming that a new technology impacted the feasibility of dog vaccination, reasonably improving current practices. The 
distribution of aggregate costs components was estimated based on previous literature (41, 42, 44).
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demand, thorough analyses of global vaccine production capac-
ity is needed. During rinderpest elimination AU-PANVAC was 
created to monitor quality of vaccine used in Africa (60). Similar 
approaches for vaccine capacity and quality monitoring should be 
adapted and implemented for GDREP.
This analysis shows that there may be an adequate veterinary 
workforce to vaccinate dogs to desired levels if this workforce 
can be utilized appropriately. This estimate has several poten-
tial limitations, including a lack of validation of the reported 
capacity in the OIE database and the assumption that the entire 
workforce would be able to dedicate time to vaccination of dogs. 
Each country is likely to address vaccination in a method that 
suits their specific capabilities. Vaccination of dogs has been 
carried out successfully by veterinarians, para-veterinarians, 
international organizations, and/or students, depending on the 
campaign design. Students were not considered a resource in 
this analysis, as they are unlikely to represent a reproducible and 
reliable resource in the majority of dog rabies endemic countries 
when considering mass vaccination on a national scale. While 
there may be scenarios in which there exists the capacity to 
vaccinate the required amount of dogs, diverting veterinary 
personnel to dog vaccination is likely to take them away from 
other disease control activities. Depending on the resources 
available, and the time commitment required, national vac-
cination programs would need to consider whether they have 
the current human capacity for rabies elimination or if more 
human capacity will need to be developed. The supplemental 
tables developed for this analysis could be used as a preliminary 
guide for national programs to determine what resources may 
be required.
While adequate resources for global rabies elimination appear 
to be lacking, it is not unrealistic to expect that new advances in 
control techniques and resources will be developed. We analyzed 
several hypothetical improvements to determine the potential 
impact they could have on rabies elimination. Dog rabies vac-
cines, including syringes and needles, account for approximately 
27% of the cost to vaccinate a dog (41, 42, 44). While investments 
in cheaper vaccines are likely to have an impact toward the elimi-
nation goal, the costs of personnel and overhead and other costs 
represent a larger proportion of the cost to vaccinate a dog. There 
is vast documented variation in daily dog vaccination capacity 
(39, 50–53), which may be a relatively low-hanging fruit for cost 
reduction. By doubling a vaccinator’s daily efficiency from 100 to 
200 dogs, the total cost to eliminate dog rabies dropped by over 
14%. Current technologies such as oral rabies vaccination and 
applications that improve logistical coordination may be key to 
improving vaccinator efficiency.
Perhaps the most debatable hypothetical scenario considered 
in this analysis is the global reduction of the dog population. 
Currently, only surgical sterilization is used for large-scale 
operations, and the capacity to sterilize the required number of 
dogs does not exist globally. Therefore, this scenario assumes 
that new methods of population management will be developed. 
One such method is an injectable sterilizing agent, of which 
several candidates have appeared on the market in recent years. 
However, their use in mass sterilization has not yet been realized 
nor evaluated, and the cost for these injectable sterilizing agents 
is still prohibitive for most countries. Our analysis suggests that 
if an effective sterilizing agent was available at the current cost of 
$8 per sterilized female dog (including personnel and overhead), 
FigUre 8 | rabies elimination rank scores by rabies clusters. Notes: 
elimination rank scores were estimated for each rabies cluster (4) based on 
six criteria: proportion of the cluster considered rabies free, funding gap for 
elimination, dog vaccination coverage for 2015 estimates, gap in vaccination 
workforce, average years to achieve elimination, and average human 
development index. Rank scores ranged from 16 to 84. A low rank score 
represents a theoretically quicker pathway toward elimination.
TaBle 4 | elimination rank scores for the feasibility of dog rabies elimination.























Micronesia 0 0 of 5 0.65 $0 70.0 6 0.0
Australia and New Zealand 0 0 of 2 0.92 $0 70.0 795 0.0
Western Europe 0 0 of 8 0.90 $0 70.0 −4,435 0.0
Polynesia 0 0 of 5 0.76 $0 70.0 8 0.0
Melanesia 0 0 of 4 0.57 $0 70.0 −193 0.0
Northern America 0 0 of 2 0.91 $0 76.1 −973 0.0
Group 1 Northern Europe 16 3 of 10 0.87 $444,538 68.6 −1,213 2.7
Southern Europe 22 6 of 13 0.82 $2,395,923 64.8 −158 4.5
Caribbean 28 3 of 13 0.72 $2,694,433 43.4 2,663 2.9
Central America 31 4 of 8 0.68 $0 72.4 −6,689 5.0
Eastern Asia 37 3 of 5 0.78 $35,848,426 36.8 21,315 7.8
Eastern Europe 39 10 of 10 0.78 $18,956,245 46.2 36,090 8.9
South America 40 9 of 13 0.73 $12,631,906 58.7 −4,947 5.9
Group 2 Western Asia 51 16 of 17 0.73 $25,414,328 31.1 3,704 9.5
Central Asia 52 5 of 5 0.66 $5,394,654 28.9 5,165 10.4
Southern Africa 56 5 of 5 0.57 $1,726,750 53.1 −1,239 12.0
Northern Africa 60 6 of 6 0.63 $22,562,725 17.3 9,302 10.8
South-Eastern Asia 63 7 of 11 0.64 $56,600,142 25.3 −9,725 7.6
Grou 3 Middle Africa 74 8 of 9 0.46 $20,372,954 0.6 −3,894 12.2
Eastern Africa 75 14 of 17 0.44 $56,414,022 4.1 −3,606 11.4
Southern Asia 78 8 of 9 0.55 $190,629,398 13.2 −19,724 10.8
Western Africa 84 15 of 16 0.41 $42,702,854 6.7 −7,205 12.6
aCountry clusters were given a ranked score based on the following criteria: proportion of the cluster that was considered rabies free, HDI, estimated funding gap for elimination, 
current dog vaccination coverage, gap in vaccinator capacity, and expected years to achieve elimination. Each of the six criteria was ordered from most optimal to least optimal 
value and received the corresponding numerical score, we summed the country cluster rank scores to obtain a cumulative rabies elimination rank score. Lower scores represent UN 
Regions that appear to be more favorably situated to achieve the rabies elimination goal.
bIncludes all vet professionals marked as “public health” and assumes they can vaccinate 100 dogs per day and they can work 25 days per year on rabies vaccination (1 month).
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the estimated total cost for global elimination would still be 
substantially higher (~40%) than in the scenario with no popula-
tion control. Only considering rabies control, to be comparable 
in terms of total costs an effective sterilizing agent would need 
to be produced at less than about $3.50 per dog (conditional on 
the assumptions in our model). Country-specific socio-cultural 
characteristics, legislation, and dog ownership, among other fac-
tors, would need close consideration in such scenario.
If we are to achieve the goal of dog-mediated human rabies 
elimination by 2030, we cannot wait for technological advances. 
It is also unlikely that, in the near-future, the global community 
will raise the total financial resources we predict are necessary to 
achieve this goal. Prioritization of countries or regional clusters 
for the finite available resources may be required. This study pro-
vides one possible method for considering resource prioritization 
through an elimination rank score. Three groupings of countries 
were identified, one group that appears to be nearing elimina-
tion, a group that is in the process of controlling dog rabies, and 
a group that appears to be at an early stage in their dog rabies 
control efforts. If prioritization of limited resources is a reality 
the rabies community must face, then international partners 
should address a global strategy where limited resources can be 
effectively distributed to begin making strategic regional progress 
toward the global target. Internationally sponsored vaccination 
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programs of tens of thousands of dogs may benefit a community 
and assist with raising awareness or collect scientific data, but 
these small-scale vaccination efforts will not achieve elimination 
globally. If considering global elimination, there should be a 
discussion over whether resources are directed toward countries 
that are nearing elimination, to ensure they complete and thereby 
open up their resources and capacity to others sooner, or whether 
the focus should be directed toward countries with the highest 
rabies burden, where a larger reduction in human deaths from 
dog rabies would occur. In either case, if more resources are not 
allocated, and in a strategic manner, then global elimination of 
dog rabies by 2030 is unlikely to be achieved.
Achieving global dog rabies elimination will require unique 
regional and national strategies. Funding, vaccination methods, 
personnel, and technological advances will be utilized differently. 
Countries will progress at the pace set by their governments and 
with assistance by international supporters, not at the predicted 
pace of the 13-year elimination program utilized in this analysis. 
Natural disasters, human-made disasters, competing needs, 
political processes, economic stagnation, and other unpredict-
able events will undoubtedly derail rabies elimination efforts in 
some countries. But the information provided here can be used to 
discuss and advocate, in a quantifiable manner, the approximate 
resources that will be required, the technological advances that 
should be pursued, and the prioritization processes that may be 
necessary. We hope that these results help stimulate and inform 
a necessary discussion on global and regional strategic planning, 
resource mobilization, and continuous execution of rabies virus 
elimination.
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